Zhitong Finance App News, Jilin Aodong (000623.SZ) issued an announcement. Recently, the company's holding subsidiary, Jilin Aodong Taonan Pharmaceutical Co., Ltd. (“Taonan Pharmaceutical”), received the specifications of pibesilil capsules issued by the State Drug Administration: 100 mg, 75 mg, 125 mg, three “Drug Registration Certificates” and pibesilil's “Notice of Approval of the Marketing Application for Chemical Ingredients”.

The approval of pibesilil capsules and pibesilil APIs improved the company's product structure, further enriched the company's raw materials and capsule formulations, enhanced the company's core competitiveness, and created favorable conditions for the company's further development.